# Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer

> **NCT00401180** · PHASE1 · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 25 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** docetaxel
- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00401180
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2011-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00401180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00401180, "Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00401180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*